HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Saori Uoyama Selected Research

Legionnaires' Disease (Legionnaire's Disease)

10/2009[Therapeutic efficacy of levofloxacin against a model of replicable Legionella pneumophila lung infection in DBA/2 mice].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Saori Uoyama Research Topics

Disease

3Infections
10/2009 - 01/2008
1Legionnaires' Disease (Legionnaire's Disease)
10/2009
1Pneumonia (Pneumonitis)
01/2008
1Community-Acquired Infections
01/2008

Drug/Important Bio-Agent (IBA)

1QuinolonesIBA
10/2009
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2009
1Levofloxacin (Levaquin)FDA Link
10/2009
1Anti-Infective Agents (Microbicides)IBA
10/2009
1Moxifloxacin (Avelox)FDA Link
01/2008
17- (7- amino- 7- methyl- 5- azaspiro(2.4)heptan- 5- yl)- 6- fluoro- 1- (2- fluoro- 1- cyclopropyl)- 1,4- dihydro- 8- methoxy- 4- oxo- 3- quinolinecarboxylic acidIBA
01/2008
1FluoroquinolonesIBA
01/2008

Therapy/Procedure

1Therapeutics
10/2009